Application of MicroRNA in Diagnosis and Treatment of Ovarian Cancer
Kouji Banno(Keio University), Daisuke Aoki(International University of Health and Welfare), Iori Kisu(Fujita Health University), Yuya Nogami(Keio University), Hiroyuki Nomura(Keio University), Masataka Adachi(Keio University), Eiichiro Tominaga(Keio University), Fumio Kataoka(Keio University), Megumi Yanokura(Keio University), Kenta Masuda(Keio University), Kiyoko Umene(Keio University), K. Nakamura(Teikyo Heisei University), Miho Iida(Keio University)
Cited by 65
Related Papers
Pathological Steps of Cancer-Related Lymphedema: Histological Changes in the Collecting Lymphatic Vessels after Lymphadenectomy
|PLoS ONE|2012|331
Durvalumab versus placebo with chemoradiotherapy for locally advanced cervical cancer (CALLA): a randomised, double-blind, phase 3 trial
|The Lancet Oncology|2023|214
MicroRNA in Cervical Cancer: OncomiRs and Tumor Suppressor miRs in Diagnosis and Treatment
|The Scientific World JOURNAL|2014|143
Cross‐sectional analysis of germline <i>BRCA</i>1 and <i>BRCA</i>2 mutations in Japanese patients suspected to have hereditary breast/ovarian cancer
|Cancer Science|2008|105
Registry of the International Society of Uterus Transplantation: First Report
|Transplantation|2022|100